| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 70.333 | 72.695 | 61.717 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 70.334 | 72.695 | 61.717 |
| Total Expenses - EUR | - | - | - | - | - | - | 11.535 | 93.202 | 128.474 | 140.244 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -11.535 | -22.868 | -55.779 | -78.527 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -11.535 | -23.572 | -56.507 | -78.527 |
| Employees | - | - | - | - | - | - | 0 | 0 | 8 | 12 |
Check the financial reports for the company - Marlaviclau Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 2.901 |
| Current Assets | - | - | - | - | - | - | 103 | 3.381 | 1.733 | 4.575 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 80 | 799 | 4.477 |
| Cash | - | - | - | - | - | - | 103 | 3.301 | 934 | 97 |
| Shareholders Funds | - | - | - | - | - | - | -11.494 | -35.102 | -91.502 | -169.518 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 11.597 | 38.483 | 93.235 | 176.994 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8730 - 8730" | |||||||||
| CAEN Financial Year |
8730
|
|||||||||
Comments - Marlaviclau Medical S.r.l.